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Introduction
Atherosclerosis is an inflammatory disease of the vessel
wall with unstable lesions being associated with the pres-
ence of inflammatory cells, smooth muscle cell apoptosis,
and the accumulation of LDL. Dextran coated superpara-
magnetic iron oxide (SPIO) nanoparticles (~20 nm) have
been shown to allow for imaging of plaque resident mac-
rophages approximately >24 h post intravenous injection.
Citrate coated very small iron oxide (VSOP) nanoparticles
(~7 nm) have been found useful for steady state aortic and
coronary MR angiography (MRA) but also have been
shown to accumulate in advanced aortic lesions in a rab-
bit model of atherosclerosis.
Purpose
In this study we wanted to test the hypothesis whether the
combined use of an extracellular matrix specific Gd-based
contrast agent (BMS753951) together with a VSOP nano-
particle would allow the exclusive visualization of the
pathologically altered coronary vessel wall in an animal
model of coronary intervention.
Methods
Placement of MR-lucent prototype stents was performed
in the proximal left coronary artery (LAD) of two female
domestic swine (~30 kg). Following a one week normal
diet, coronary MRA and delayed enhancement vessel wall
imaging was performed using a 1.5 T Philips Achieva MR
scanner. Immediately before the imaging session, animals
were injected with 0.1 mmol/kg BMS753951, an elastin-
binding low molecular weight Gd-based contrast agent
(Bristol Myers Squibb, Billerica, MA). After localization of
the heart, coronary MRA was performed using a steady
state free precession imaging sequence. ~30 minutes post
BMS753951 injection, delayed enhancement coronary
wall imaging was performed with spatial resolution, slice
thickness and image orientation maintained using an
inversion recovery (IR) fast gradient echo technique. Sub-
sequently, 60 μmol/kg VSOP (Ferropharm, Teltow, Ger-
many) was injected and IR coronary MRA was performed
with the inversion delay adjusted to minimize signal from
myocardium. 45 minutes post VSOP administration,
delayed enhancement vessel wall imaging was repeated
with the inversion time adjusted to minimize signal from
arterial blood. Immediately after the MRI session, animals
were euthanized and hearts were harvested for histologi-
cal examination.
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Strong enhancement of the stented left coronary artery
and no apparent enhancement of the non-injured right
coronary artery (RCA) was observed in both animals ~30
minutes post administration of BMS753951 (Figure 1b)
suggestive for ECM formation in the stented coronary
artery segment. In addition, strong enhancement was also
present in the aorta and pulmonary arteries (Figure 1b)
due to the high elastin content in those vessels. Immedi-
ately post injection of VSOP, free-breathing inversion
recovery MRA yielded good visualization of the blood
pool in large vessels and also good visualization of the
stented LAD but with attenuated luminal signal when
compared to the large and coronary control vessels (Fig-
ure 1c). In addition, a black rim artifact delineating the
stented LAD was observed (Figure 1c) while no such effect
was seen in the aorta and pulmonary artery nor in the cor-
onary control vessel suggestive for VSOP uptake in the
injured vessel wall (increased T2* effect of bound VSOP).
This finding was confirmed by a delayed enhancement
scan with the inversion time adjusted for blood signal nul-
ling, which demonstrated ECM enhancement in the aortic
and pulmonary vessel wall but disappearance of enhance-
ment in the LAD vessel wall (Figure 1b vs. 1d).
Conclusion
We demonstrate the exclusive visualization of VSOP nan-
oparticles in the injured coronary vessel as a black rim
artifact on coronary MRA. In addition, with the combined
use of a matrix specific contrast agent, focal uptake of
VSOP nanoparticles in the injured coronary vessel wall
could be confirmed as displacement of the gadolinium
signal seen after BMS753951 injection. In conclusion,
VSOP nanoparticles have been shown to be useful for the
detection pathological changes in the coronary vessel wall
We demonstrate the combined use of a matrix specific Gd-based contrast agent (BMS753951) together with an iron oxide nanoparticle for exclusive v sualization of the pathologically altered coronary vessel wallFigur  1
We demonstrate the combined use of a matrix specific Gd-based contrast agent (BMS753951) together with 
an iron oxide nanoparticle for exclusive visualization of the pathologically altered coronary vessel wall. (A) Cor-
onary angiogram of stented and balloon injured left coronary artery. Note that there are no artifacts from the bare metal stent. 
(B) T1 weighted inversion recovery delayed enhancement coronary vessel wall scan post BMS753951 injection demonstrating 
extracellular matrix formation one week post stent placement and injury. (C) Coronary MRA post VSOP injection demon-
strating a strong T1 effect of the large vessels but an attenuated blood signal in the LAD suggestive for VSOP accumulation in 
the injured vessel wall (increased T2* effect of bound VSOP). (D) Delayed enhancement coronary vessel wall scan post 
BMS753951 and VSOP injection demonstrating displacement of the BMS753951 signal in the LAD due to VSOP accumulation 
in the injured vessel wall.Page 2 of 3
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and potentially may be useful for the detection unstable
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